Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05428748 · ClinicalTrials.gov registry record · NA
Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers
A NA study, sponsored by Liquid I.V..
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05428748 is a NA study that has completed, run by Liquid I.V.. The registered enrollment target is 40 participants.
The verdict
NCT05428748, a NA study, has completed, sponsored by Liquid I.V..
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This clinical trial design aims to evaluate the safety and tolerability of a novel hydration drink in health volunteers.
Interventions
- OTHER Placebo
- OTHER 1 serving of test product
- OTHER 2 servings of test product
- OTHER 3 servings of test product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05428748
The ClinicalTrials.gov registry entry for NCT05428748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Liquid I.V., which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT05428748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05428748 about?
NCT05428748 is a clinical study titled "Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers". This clinical trial design aims to evaluate the safety and tolerability of a novel hydration drink in health volunteers.
What is the current status of trial NCT05428748?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-01. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT05428748?
The interventions under investigation include: Placebo (OTHER), 1 serving of test product (OTHER), 2 servings of test product (OTHER), 3 servings of test product (OTHER).
Who is sponsoring clinical trial NCT05428748?
This trial is sponsored by Liquid I.V., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.